Clinical Trial Update: Effect of a Nasal Bolus Allergen Challenge on Inflammatory Markers [Phase 1]

View source ↗

Summary

Pfizer-conducted Phase 1 trial evaluating the effect of a nasal bolus allergen challenge on inflammatory markers in seasonal allergic rhinitis; the study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Snippet

Sponsor: Pfizer | Conditions: Seasonal Allergic Rhinitis | Phase 1 | Status: COMPLETED